Document Detail


Innovative Surgical Strategies: Minimally Invasive CABG and Off-pump CABG.
MedLine Citation:
PMID:  15023283     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Minimally invasive coronary artery bypass grafting (CABG) and off-pump coronary artery bypass grafting (OPCAB) have made up a significant facet of the recent attempts of surgical myocardial revascularization to evolve. Driven by an effort to limit the deleterious effects of cardiopulmonary bypass (CPB), along with a response to both the growing interests in performing procedures through smaller incisions and the successes of catheter-based therapies, these therapeutic options have found themselves moving into the future by resurrecting their past. Minimally invasive CABG is the procedure by which coronary grafting is performed through a small anterior thoracotomy, without the use of CPB. Although feasible, the inability to offer a more thorough degree of revascularization has limited the applicability of this procedure and, therefore, accounts for its overall minor contribution to the number of coronary revascularizations performed annually. Conversely, as the technical feasibility of performing complete revascularization without CPB has been achieved with OPCAB, its place as a mode of therapy remains uncertain. Several clinical trials have been performed to date with only a few being done in a prospective, randomized fashion. From this data has come a mix of information regarding either improvements or, at a minimum, no change in the rate of complications between CABG with, and without, CPB, while at the same time maintaining equivalent short-term graft patencies. The question remains, however, to which patient population is this approach to CABG optimal? Our practice has largely reserved OPCAB for those patients in whom manipulation of the aorta is considered not feasible due to severe calcification or in "high-risk" patients who are felt to be unable to tolerate the adverse physiologic effects of CPB. This makes up approximately 15% of our CABG population, roughly equal to the national average, with the remaining patients being revascularized with the assistance of CPB.
Authors:
Afshin Ehsan; Prem Shekar; Sary Aranki
Related Documents :
10028543 - Early postoperative complications after coronary artery bypass grafting at the cardiova...
9679483 - Coronary artery bypass grafting in canada: national and provincial mortality trends, 19...
11806793 - Systematic adjudication of myocardial infarction end-points in an international clinica...
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Current treatment options in cardiovascular medicine     Volume:  6     ISSN:  1534-3189     ISO Abbreviation:  Curr Treat Options Cardiovasc Med     Publication Date:  2004 Feb 
Date Detail:
Created Date:  2004-Mar-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815942     Medline TA:  Curr Treat Options Cardiovasc Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  43-51     Citation Subset:  -    
Affiliation:
Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. saranki@partners.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Therapeutic Strategies for Cardiogenic Shock.
Next Document:  Transmyocardial Laser Revascularization.